Anemia After Renal Transplantation: An Underestimated Problem

Transplantation Proceedings

Volumn 40, Issue 10, 2008, Pages 3481-3484

  Ott, U ^a   Busch, M ^a   Steiner, T ^a   Wolf, G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; AZATHIOPRINE; CREATININE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HEMOGLOBIN; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ADULT; AGED; ANEMIA; ARTICLE; BK VIRUS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 57549105859     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.07.139     Document Type: Article

References (22)

1. Muirhead N. Erythropoietin and renal transplantation. Kidney Int 69 (1999) 86
2. Kasiske B.L. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84 (1988) 985
3. Lindholm A., Albrechtsen D., Frodin L., et al. Ischemic heart disease-major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60 (1995) 451
4. Kasiske B.L., Guijarro C., Massy Z.A., et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7 (1996) 158
5. Borrows R., Loucaidou M., Chusney G., et al. Anaemia and congestive heart failure early post-renal transplantation. Nephrol Dial Transplant 23 (2008) 1728
6. Rigatto C., Foley R., Jeffery J., et al. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 14 (2003) 462
7. Rigatto C., Parfrey P., Foley R., et al. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 13 (2002) 1084
8. Hsu C.Y., McCulloch C.E., and Curhan G.C. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 13 (2002) 504
9. Vanrenterghem Y., Ponticelli C., Morales J.M., et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 3 (2003) 835
10. Lorenz M., Kletzmayr J., Perschl A., et al. Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 13 (2002) 794
11. Saito S., Fujiwara T., Sakagami K., et al. Anemia following renal transplantation. Transplant Proc 30 (1998) 3025
12. Miles A.M., Markell M.S., Daskalakis P., et al. Anemia following renal transplantation: erythropoietin response and iron deficiency. Clin Transplant 11 (1997) 313
13. Molnar M.Z., Novak M., Ambrus C., et al. Anemia in kidney transplanted patients. Clin Transplant 19 (2005) 825
14. Winkelmayer W.C., Lorenz M., Kramar R., et al. Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant 4 (2004) 2075
15. Heinze G., Mitterbauer C., Regele H., et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 17 (2006) 889
16. Kasiske B.L., Vazquez M.A., Harmon W.E., et al. Recommendations for the outpatient surveillance of renal transplant recipients. J Am Soc Nephrol 11 suppl 15 (2000) 1
17. US Renal Data System. USRDS 2001 Annual Report (2001), National Institute of Health, Bethesda, Md
18. Parfrey P.S., Vavasour H.M., and Gault M.H. A prospective study of health status in dialysis and transplant patients. Transplant Proc 20 (1988) 1231
19. Almond M.K., Tailor D., Marsh F.P., et al. Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme. Nephrol Dial Transplant 9 (1994) 270
20. Vanwalleghem J.F., and Vanrenterghem Y.F.C. Hematologic considerations of organ transplantation. In: Ginns L.C., Cosimi A.B., and Morris P.J. (Eds). Transplantation (1999), Blackwell Science, Malden 685
21. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 345 (1995) 1321
22. Shah N., Al Khoury S., Afzall B., et al. Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation 81 (2006) 1112